← SynDRA
MK-0941 FREE BASE
SynDRA canonical compound SYN0038317 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | GCK |
|---|
| Mechanism of action | glucokinase activator |
|---|
| Indication | diabetes mellitus |
|---|
| Disease area | endocrinology |
|---|
All known targets
Mechanisms of action (all sources)
- GCK ACTIVATOR
- Hexokinase type IV activator
- glucokinase activator
Cross-references
Synonyms
- YZ1L3KR377
- MK-0941 (free base)
- UNII-YZ1L3KR377
- MK-0941 Free
- orb1309419
- SCHEMBL2883693
- SCHEMBL29694365
- HY-19843A
- AKOS040733748
- AC-35815
- DA-65496
- TS-07836
- CS-0086166
- T12056
- 3-(6-ethylsulfonylpyridin-3-yl)oxy-5-[(2S)-1-hydroxypropan-2-yl]oxy-N-(1-methylpyrazol-3-yl)benzamide
- MS-30140
- UNII-83OY2D8970
- MK0941
- Mk-0941
- HY-19843
- CS-0017017
- G15930
- mk-0941
- EX-A1851
- SCHEMBL2889404
- C22H28N4O9S2
- MK-0941 mesylate
- MK-0941?
- AKOS040733749
- AC-35437
- MVB91697
- DA-55518
- MFCD30532700
- RefChem:159183
Look up MK-0941 FREE BASE in the interactive SynDRA portal →